BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37790330)

  • 1. Long-read sequencing resolves a complex structural variant in
    Daida K; Funayama M; Billingsley KJ; Malik L; Miano-Burkhardt A; Leonard HL; Makarious MB; Iwaki H; Ding J; Gibbs JR; Ishiguro M; Yoshino H; Ogaki K; Oyama G; Nishioka K; Nonaka R; Akamatsu W; Blauwendraat C; Hattori N
    medRxiv; 2023 Aug; ():. PubMed ID: 37790330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease.
    Daida K; Funayama M; Billingsley KJ; Malik L; Miano-Burkhardt A; Leonard HL; Makarious MB; Iwaki H; Ding J; Gibbs JR; Ishiguro M; Yoshino H; Ogaki K; Oyama G; Nishioka K; Nonaka R; Akamatsu W; Blauwendraat C; Hattori N
    Mov Disord; 2023 Dec; 38(12):2249-2257. PubMed ID: 37926948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's disease.
    Zhu W; Huang X; Yoon E; Bandres-Ciga S; Blauwendraat C; Billingsley KJ; Cade JH; Wu BP; Williams VH; Schindler AB; Brooks J; Gibbs JR; Hernandez DG; Ehrlich D; Singleton AB; Narendra DP
    Brain; 2022 Jun; 145(6):2077-2091. PubMed ID: 35640906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-read sequencing unravels the complexity of structural variants in
    Cogan G; Daida K; Billingsley KJ; Tesson C; Forlani S; Jornea L; Arnaud L; Tissier L; LeGuern E; Singleton AB; Ferrien M; Gervais Bernard H; Lesage S; Blauwendraat C; Brice A
    medRxiv; 2024 May; ():. PubMed ID: 38746197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa-responsive dystonia caused by biallelic
    Mor-Shaked H; Paz-Ebstein E; Basal A; Ben-Haim S; Grobe H; Heymann S; Israel Z; Namnah M; Nitzan A; Rosenbluh C; Saada A; Tzur T; Yanovsky-Dagan S; Zaidel-Bar R; Harel T; Arkadir D
    Brain Commun; 2021; 3(3):fcab197. PubMed ID: 34514401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
    Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR
    Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Heterozygous PRKN Variants and Copy-Number Variations in Parkinson's Disease.
    Yu E; Rudakou U; Krohn L; Mufti K; Ruskey JA; Asayesh F; Estiar MA; Spiegelman D; Surface M; Fahn S; Waters CH; Greenbaum L; Espay AJ; Dauvilliers Y; Dupré N; Rouleau GA; Hassin-Baer S; Fon EA; Alcalay RN; Gan-Or Z
    Mov Disord; 2021 Jan; 36(1):178-187. PubMed ID: 32970363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlation in PRKN-associated Parkinson's disease.
    Menon PJ; Sambin S; Criniere-Boizet B; Courtin T; Tesson C; Casse F; Ferrien M; Mariani LL; Carvalho S; Lejeune FX; Rebbah S; Martet G; Houot M; Lanore A; Mangone G; Roze E; Vidailhet M; Aasly J; Gan Or Z; Yu E; Dauvilliers Y; Zimprich A; Tomantschger V; Pirker W; Álvarez I; Pastor P; Di Fonzo A; Bhatia KP; Magrinelli F; Houlden H; Real R; Quattrone A; Limousin P; Korlipara P; Foltynie T; Grosset D; Williams N; Narendra D; Lin HP; Jovanovic C; Svetel M; Lynch T; Gallagher A; Vandenberghe W; Gasser T; Brockmann K; Morris HR; Borsche M; Klein C; Corti O; Brice A; Lesage S; Corvol JC;
    NPJ Parkinsons Dis; 2024 Mar; 10(1):72. PubMed ID: 38553467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic study of early-onset Parkinson's disease in the Malaysian population.
    Tay YW; Tan AH; Lim JL; Lohmann K; Ibrahim KA; Abdul Aziz Z; Chin YT; Mawardi AS; Lim TT; Looi I; Chia YK; Ooi JCE; Cheah WK; Dy Closas AMF; Lit LC; Hor JW; Toh TS; Muthusamy KA; Bauer P; Skrahin V; Rolfs A; Klein C; Ahmad-Annuar A; Lim SY
    Parkinsonism Relat Disord; 2023 Jun; 111():105399. PubMed ID: 37209484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the relationship between monoallelic PRKN mutations and Parkinson's risk.
    Lubbe SJ; Bustos BI; Hu J; Krainc D; Joseph T; Hehir J; Tan M; Zhang W; Escott-Price V; Williams NM; Blauwendraat C; Singleton AB; Morris HR;
    Hum Mol Genet; 2021 Mar; 30(1):78-86. PubMed ID: 33448283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population.
    Zhao Y; Qin L; Pan H; Liu Z; Jiang L; He Y; Zeng Q; Zhou X; Zhou X; Zhou Y; Fang Z; Wang Z; Xiang Y; Yang H; Wang Y; Zhang K; Zhang R; He R; Zhou X; Zhou Z; Yang N; Liang D; Chen J; Zhang X; Zhou Y; Liu H; Deng P; Xu K; Xu K; Zhou C; Zhong J; Xu Q; Sun Q; Li B; Zhao G; Wang T; Chen L; Shang H; Liu W; Chan P; Xue Z; Wang Q; Guo L; Wang X; Xu C; Zhang Z; Chen T; Lei L; Zhang H; Wang C; Tan J; Yan X; Shen L; Jiang H; Zhang Z; Hu Z; Xia K; Yue Z; Li J; Guo J; Tang B
    Brain; 2020 Jul; 143(7):2220-2234. PubMed ID: 32613234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of PRKN structural variations identified through whole-genome sequencing.
    Bravo P; Darvish H; Tafakhori A; Azcona LJ; Johari AH; Jamali F; Paisán-Ruiz C
    Mol Genet Genomic Med; 2018 Nov; 6(6):1243-1248. PubMed ID: 30328284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of Heterozygous Parkin (
    Castelo Rueda MP; Raftopoulou A; Gögele M; Borsche M; Emmert D; Fuchsberger C; Hantikainen EM; Vukovic V; Klein C; Pramstaller PP; Pichler I; Hicks AA
    Front Neurol; 2021; 12():706145. PubMed ID: 34434164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson's disease.
    Li T; Kou D; Cui Y; Le W
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-occurrence of PRKN and SYNJ1 variants in Early-Onset Parkinson's disease.
    Cotrin JC; Piergiorge RM; Gonçalves AP; Pereira JS; Gerber AL; de Campos Guimarães AP; de Vasconcelos ATR; Santos-Rebouças CB
    Metab Brain Dis; 2024 Jun; ():. PubMed ID: 38836947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: Early-onset Parkinson's disease with initial spastic paraparesis and hyperreflexia caused by compound heterozygous
    Jensen I; Hendrich C; Klietz M; Berding G; Höglinger GU; Wegner F
    Front Neurol; 2022; 13():969232. PubMed ID: 36468052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-based burden analysis of damaging private variants in PRKN, PARK7 and PINK1 in Parkinson's disease cohorts of European descent.
    Hu J; Waters CH; Spiegelman D; Fon EA; Yu E; Asayesh F; Krohn L; Saini P; Alcalay RN; Hassin-Baer S; Gan-Or Z; Krainc D; Zhang B; Bustos BI; Lubbe SJ;
    Neurobiol Aging; 2022 Nov; 119():136-138. PubMed ID: 36305379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkin mutations and early-onset parkinsonism in a Taiwanese cohort.
    Wu RM; Bounds R; Lincoln S; Hulihan M; Lin CH; Hwu WL; Chen J; Gwinn-Hardy K; Farrer M
    Arch Neurol; 2005 Jan; 62(1):82-7. PubMed ID: 15642853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Han Chinese Family With Early-Onset Parkinson's Disease Carrying Novel Frameshift Mutation and Compound Heterozygous Mutation of
    Gao C; Huang T; Chen R; Yuan Z; Tian Y; Zhang Y
    Front Neurol; 2020; 11():582323. PubMed ID: 33154736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the canvas of PRKN mutations in familial and early-onset Parkinson disease.
    Pandey S; Tomar LR; Kumar S; Dinesh S; Thelma BK
    Parkinsonism Relat Disord; 2019 Sep; 66():216-219. PubMed ID: 31409571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.